Related Experiment Videos

Genetic prodrug activation therapy for pancreatic cancer

A S Rigg¹, N R Lemoine

¹Imperial Cancer Research Fund Molecular Oncology Unit, Hammersmith Hospital, Imperial College School of Medicine, London, UK.

Annals of the New York Academy of Sciences

|July 23, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Pancreatic Cancer UK Grand Challenge: Developments and challenges for effective CAR T cell therapy for pancreatic ductal adenocarcinoma.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2020

ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation.

Oncogene·2016

Lister strain vaccinia virus with thymidine kinase gene deletion is a tractable platform for development of a new generation of oncolytic virus.

Gene therapy·2015

The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models.

Gene therapy·2011

An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine.

Cancer gene therapy·2011

Intratumoral gene transfer of the Cytosine deaminase gene for the treatment of breast cancer.

Methods in molecular medicine·2011

See all related articles